These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. Kotanko P; Kramar R; Devrnja D; Paschke E; Voigtländer T; Auinger M; Pagliardini S; Spada M; Demmelbauer K; Lorenz M; Hauser AC; Kofler HJ; Lhotta K; Neyer U; Pronai W; Wallner M; Wieser C; Wiesholzer M; Zodl H; Födinger M; Sunder-Plassmann G J Am Soc Nephrol; 2004 May; 15(5):1323-9. PubMed ID: 15100373 [TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of Anderson Fabry disease in a Romanian family. Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300 [TBL] [Abstract][Full Text] [Related]
13. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. MacDermot KD; Holmes A; Miners AH J Med Genet; 2001 Nov; 38(11):750-60. PubMed ID: 11694547 [TBL] [Abstract][Full Text] [Related]
14. Pathologic substrate of gastropathy in Anderson-Fabry disease. Di Toro A; Narula N; Giuliani L; Concardi M; Smirnova A; Favalli V; Urtis M; Alvisi C; Antoniazzi E; Arbustini E Orphanet J Rare Dis; 2020 Jun; 15(1):156. PubMed ID: 32571412 [TBL] [Abstract][Full Text] [Related]
15. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry. Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394 [TBL] [Abstract][Full Text] [Related]
16. Cardiac manifestations of Anderson-Fabry disease in heterozygous females. Kampmann C; Baehner F; Whybra C; Martin C; Wiethoff CM; Ries M; Gal A; Beck M J Am Coll Cardiol; 2002 Nov; 40(9):1668-74. PubMed ID: 12427421 [TBL] [Abstract][Full Text] [Related]
17. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335 [TBL] [Abstract][Full Text] [Related]
18. Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation. Yamamoto S; Nagasawa T; Sugimura K; Kanno A; Tatebe S; Aoki T; Sato H; Kozu K; Konno R; Nochioka K; Satoh K; Shimokawa H Intern Med; 2019 Feb; 58(4):603-607. PubMed ID: 30333391 [TBL] [Abstract][Full Text] [Related]
19. High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations. Nakagawa N; Sawada J; Sakamoto N; Takeuchi T; Takahashi F; Maruyama JI; Momosaki K; Nakamura K; Endo F; Hasebe N J Hum Genet; 2019 Sep; 64(9):891-898. PubMed ID: 31213654 [TBL] [Abstract][Full Text] [Related]
20. Natural history of the respiratory involvement in Anderson-Fabry disease. Magage S; Lubanda JC; Susa Z; Bultas J; Karetová D; Dobrovolný R; Hrebícek M; Germain DP; Linhart A J Inherit Metab Dis; 2007 Oct; 30(5):790-9. PubMed ID: 17619837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]